Evaluation of p53 and BCL-2 genes and proteins expression in human breast cancer T47D cells treated with extracts of Astrodaucus persicus (Boiss.) drude in comparison to tamoxifen

Daru

Volumn 17, Issue 3, 2009, Pages 181-186

  Azizi, E ^a   Abdolmohammadi, M H ^a,c   Fouladdel, Sh ^a   Shafiee, A ^a   Amin, Gh ^b   Ghaffari, S M ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Astrodaucus persicus; Immunocytochemistry; p53 and Bcl 2 gens; RT PCR; T47D cells

Indexed keywords

ASTRODAUCUS PERSICUS EXTRACT; COUMARIN DERIVATIVE; PLANT EXTRACT; PROTEIN BCL 2; PROTEIN P53; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PLANT ROOT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 70350336450     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kumar R, Vadlamudi R K, Adam L. Apoptosis in mammary gland and cancer. Endocr-relat Cancer 2000; 7: 257-269.
2. McPherson K, Steel C M, Dixon J M. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321: 624-628.
3. Ingvarsson S. Breast cancer: Introduction, Semin Cancer Biol 2001; 11: 323-326.
4. Gasco M, Crook T. p53 family members and chemoresistance in cancer: what we know and what we need to know. Drug Resist Update 2003; 6: 323-328. (Pubitemid 38173583)
5. Oren M. Regulation of the p53 tumor suppressor protein. J Biol Chem 1999; 274: 36031-36034. (Pubitemid 30005193)
6. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003; 116: 4077-4085.
7. Hussain S P, Harris C C. p53 biological network: At the crossroad of the cellular-stress response pathway and molecular carcinogenesis, J Nippon Med Sch 2006; 73: 54-64.
8. Droin N M, Green D R. Role of Bcl-2 family members in immunity and disease. BBA 2004; 1644: 179-188. (Pubitemid 38281274)
9. Willis S, Day C L, Hinds M G, Huang D CS. The Bcl-2-regulated apoptotic pathway. J Cell Sci 2003; 116: 4053-4056.
10. Krajewski S, Krajewski M, Turner B C, Pratt C, Howard B, Zapata J M, Frenkel V, Robertson S, Lonov Y, Yamamoto H, Perucho M, Takayama S, Reed J C. Prognostic significance of apoptosis regulators in breast cancer. Endocr-relat Cancer 1999; 6: 29-40. (Pubitemid 29197225)
11. Kaabinejadian S., Fouladdel Sh., Ramezani M, Azizi E. Molecular analysis of Bcl-2 and cyclin D1 expression in differentially expressing estrogen receptor breast cancer MCF7, T47D and MDAMB-468 cell lines treated with adriamycin. DARU 2008; 16(3): 182-188.
12. Chin Y W, Balunas M J, Chai H B, Kinghorn A D. Drug discovery from natural sources. The AAPS Journal 2006; 8: E239-E253.
13. Cragg G M, Newman D J. Plant as source of anti-cancer agents. J Ethnopharmacol 2005; 100: 72-79.
14. Balunas M J, Kinghorn A D. Drug discovery from medicinal plants. Life Sci 2005; 78: 431-441.
15. Reddy L, Odhav B, Bhoola K D. Natural products for cancer prevention: a global perspective. Pharmacol Ther 2003; 99: 1-13. (Pubitemid 36694746)
16. Srivastava V, Negi A S, Kumar J K, Gupta M M, Khanuja S P S. Plant-based anticancer molecules: A chemical and biological profile of some important leads. Bioorg Med Chem 2005; 13: 5892-5908. (Pubitemid 41399898)
17. Pezzuto J M. Plant-derived anticancer agents. Biochem Pharmacol 1997; 53: 121-133.
18. Bazargani Y T, Almasirad A, Amin G, Shafiee A. Chemical composition of the essential oils of Astrodaucus persicus (Boiss.) Drude root, stem/leaves and flowers/fruits. Flavour Fragr J 2006; 21: 294-296.
19. M.H. Salehi Surmaghi 'Y. Aynehchi GH. Amin' Z. Mahmoodi. Survey of Iranian Plants For Saponins Alkaloids Flavonoids And Tannins. IV. DARU 1992; 2(2-3): 1-11.
20. Bigdeli M, Rustaiyan M, Nazak N, Masoudi S. Essential oil of Astrodaucus persicus (Boiss.) Drude. from Iran, J Essent Oil Res 2004; 16: 420-421.
21. Abdolmohammadi M H, Fouladdel S, Shafiee A, Amin G, Ghaffari S M, Azizi E. Anticancer effects and cell cycle analysis on human breast cancer T47D cells treated with extracts of Astrodaucus persicus (Boiss.) Drude in comparison to doxorubicin. DARU 2008; 16: 112-118. (Pubitemid 351872778)
22. Aapro M S. Adjuvant therapy of primary breast cancer: A review of key findings from the 7th international conference, St Gallen. Oncologist 2001; 6: 376-385.
23. Timothy J, Hobday M D, Edith A P. Molecular targeted therapies for breast cancer. Cancer Control 2005; 12: 73-81. (Pubitemid 40647050)
24. Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga A V, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J Clin Pathol 2002; 55: 461-466. (Pubitemid 34620784)
25. Tokino T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hemat 2000; 33:1-6. (Pubitemid 30064481)
26. Yang Q, Sakurai T, Yoshimura G, Suzuma T, Umemura T, Nakmura M, Nakamura Y, Ichiro M I, Kakudo K. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy. Oncol Rep 2003; 10: 121-125.
27. Youle R J, Strasser A. The Bcl-2 protein family: Opposing activities that mediated cell death. Nature Rev 2008 ; 9: 47-59.
28. Egan D A, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes R D. The pharmacology, metabolism, analysis and application of coumarin and coumarin related compounds. Drug Metab Rev 1999; 22: 503-529.
29. Finn G J, Kenealy E, Creaven B S, Egan D A. In Vitro cytotoxic potential and mechanism of action selected coumarins. Cancer Lett 2004; 183: 61-68.